Long-term Remission After Cilta-Cel in Multiple Myeloma Is Linked to Diverse T Cells and Low Myeloid Suppression
Blood Advances, 2025
Vieira dos Santos J., Melnekoff D., Aleman A., Mouhieddine T., Montes de Oca R., Wang F., Rajeeve S., Bhalla S., Van Oekelen O., Upadhyaya B., Ghodke-Puranik Y., Leshchenko V., Kim-Schulze S., Rahman A., Afik S., Lewinsky H., Plaks V., Thibaud S., Cho H., Richter J., Rodriguez C., Sanchez L., Rossi A., Richard S., Chari A., Madduri D., Jagannath S., Parekh S., Lagana A.
| Disease area | Application area | Sample type | Products |
|---|---|---|---|
Oncology | Pathophysiology | Bone Marrow Serum | Olink Target 96 |
Abstract
No abstract